20-Week Breakout Analysis — 2026-10-29

Overview

The October 29 scan recorded 186 total 20-Week signals: 100 bullish (dollar/pct_20_wk) versus 86 bearish (dollar/pct_d20_wk). At 53.8% bullish, this falls in the Balanced range (40-70%), signaling mixed institutional sentiment rather than one-sided conviction. Breadth confirms this picture at 54.4% of names above SMA-40, with sector leadership concentrated in defensive-leaning Utilities (3.4% ATR%), Health Care (3.0%), and Materials (2.3%), while Financials, Technology, and Communication Services lag into negative ATR% territory.

Under the Cautious regime, only the highest-conviction setups should be scored 4+. Given the balanced bullish/bearish split, undefined institutional fund data across nearly every name, and leadership rotating into Health Care/Materials rather than broad-based participation, we assign a Quality Score of 3/5. Selectivity is warranted — favor names aligned with leading sectors and strong ATR multiples over speculative, low-liquidity breakouts.

Top 5 Bullish Picks

GRAL ($157.88) — Medical / Medical-Services

Open full analysis on WaveFinder →

Weekly Momentum: GRAL posted the strongest ATR Multiple of the group at 6.94x with a 9.0% ADR%, reflecting explosive volatility-adjusted movement. The stock sits just 5.2% off its 52-week high while up 280.4% from its 52-week low, confirming a powerful trend continuation within the leading Health Care sector.

Level	Price
Entry/Current	$157.88
Risk (Stop, -1 ATR)	$147.45
Target 1 (+2 ATR)	$178.74

Institutional Interest: 0 funds reported, growth_250 bucket; fund-flow data undefined this cycle, but Rel Volume of 1.1x on avg volume of 1.03M shares suggests steady accumulation building.

ICLR ($214.16) — Medical / Medical-Research

Open full analysis on WaveFinder →

Weekly Momentum: ICLR’s standout Rel Volume of 4.5x (3.94M vs 867K avg) drove an ATR Multiple of 5.82, the sharpest volume surge in the bullish cohort. Price is just 5.0% from its 52-week high and 221.7% above its 52-week low, confirming institutional-grade breakout participation in the top-performing Health Care sector.

Level	Price
Entry/Current	$214.16
Risk (Stop, -1 ATR)	$204.70
Target 1 (+2 ATR)	$233.08

Institutional Interest: 0 funds listed, funds_500 bucket; undefined fund-increase data, though the 4.5x relative volume spike is the clearest accumulation signal in this report.

LH ($360.45) — Medical / Medical-Services

Weekly Momentum: LH combined a 2.5x Rel Volume surge with an ATR Multiple of 4.53 and the highest LOD Risk ATR% in the group at 199.9%, indicating a wide intraday range breakout. Trading just 5.5% off its 52-week high, LH is a Health Care sector leader riding the group’s dominant ATR% strength.

Level	Price
Entry/Current	$360.45
Risk (Stop, -1 ATR)	$350.92
Target 1 (+2 ATR)	$379.51

Institutional Interest: 0 funds, funds_1000 bucket; funds % data undefined, but elevated relative volume supports emerging institutional attention.

MEDP ($692.68) — Medical / Medical-Research

Open full analysis on WaveFinder →

Weekly Momentum: MEDP leads the bullish list in dollar-value breakout terms at $692.68, with an ATR Multiple of 4.04 and LOD Risk ATR% of 100.2%. The stock is just 1.2% from its 52-week high, the tightest proximity to new highs among all bullish picks — a hallmark of institutional-grade strength.

Level	Price
Entry/Current	$692.68
Risk (Stop, -1 ATR)	$671.60
Target 1 (+2 ATR)	$734.84

Institutional Interest: 0 funds, funds_500 bucket; undefined fund-flow metrics, though proximity to 52-week highs on in-line relative volume (1.1x) signals quiet accumulation.

HWKN ($154.06) — Chemical / Chemicals-Basic

Weekly Momentum: HWKN posted an ATR Multiple of 6.38 with 1.3x relative volume, extending gains despite sitting 11.5% off its 52-week high. As a Chemicals name, it aligns with the Materials sector’s top-tier 2.3% ATR% leadership, offering diversification outside Health Care.

Level	Price
Entry/Current	$154.06
Risk (Stop, -1 ATR)	$149.02
Target 1 (+2 ATR)	$164.14

Institutional Interest: 0 funds reported; bucket N/A, undefined fund data. Lower liquidity bucket warrants smaller position sizing.

Bearish Alerts

Five names flagged bearish 20-week breakdowns: NVEC (-2.60 ATR Multiple, Electronics, -39.0% from 52W high), VLO (-0.39, Energy/Refining, -15.8% from high), WWD (-2.30, Aerospace/Defense, -32.6% from high), RBC (-0.92, Metals, -27.4% from high), and STRL (-2.53, Building/Heavy Construction, -61.3% from high, 2.0x Rel Volume). STRL’s deep drawdown combined with elevated relative volume marks it the most distressed name in the group, warranting defensive positioning or avoidance.

Sector Theme

Bullish breakouts are heavily concentrated in Health Care (MEDP, GRAL, ICLR, LH, BIO, TWST), directly mirroring the sector’s top ATR% ranking (3.0%). HWKN’s Chemicals exposure complements Materials’ 2.3% leadership. Conversely, bearish breakdowns span Energy, Aerospace/Defense, Metals, and Building — sectors not represented in the top ATR% leaders — while the bottom-ranked Financials, Technology, and Communication Services sectors produced only isolated bullish entries (e.g., TXN), reinforcing a rotation into defensive/health-oriented leadership consistent with the Cautious regime.

Institutional Summary

Institutional fund-count data was undefined across all 15 featured tickers, limiting direct accumulation comparisons this cycle. Bucket classifications remain the best proxy: LH and ICLR carry the highest relative volume surges (2.5x and 4.5x respectively), suggesting the earliest stages of institutional interest. MEDP’s funds_500 bucket paired with near-52-week-high positioning, and GRAL’s growth_250 classification with a 6.94 ATR Multiple, mark the two names most likely to attract incremental institutional flow if fund-reporting data normalizes next cycle.

Signals